Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.20 -0.05 (-0.13%)
As of: Sep 30, 2026 · 3:59 PM EDT

Xenon Pharmaceuticals (XENE) Capital Expenditures (2013 - 2026)

Updated

Xenon Pharmaceuticals' Capital Expenditures was $275,000 in Q2 2026, up 75.2% from $157,000 a year earlier and up 106.8% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Capital Expenditures (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Xenon Pharmaceuticals' Capital Expenditures was $1.01 million through Jun 30, 2026, down 36.0% year-over-year; for FY2025, it was $799,000, down 74.0% from FY2024.

  • Capital Expenditures shows a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $3.08 million in FY2024 (-45.3%), $5.62 million in FY2023 (+94.1%), $2.89 million in FY2022 (+41.2%) and $2.05 million in FY2021 (-22.3%).
  • Quarterly Capital Expenditures has moved between $43,000 (Q1 2025) and $2.21 million (Q1 2023) over five years.
  • Compared with a year earlier, Capital Expenditures was higher in three of the last eight quarters, with growth averaging 107.4%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q1 2023 (growth of 940.6%); the worst was Q4 2023 (a decline of 95.5%).
  • Per Business Quant data, XENE's Capital Expenditures in the three quarters before Q2 2026 was $133,000 (Q1 2026), $318,000 (Q4 2025) and $281,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn - 275,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 275,000.00
Mar 31, 2026 133,000.00
Dec 31, 2025 318,000.00
Sep 30, 2025 281,000.00
Jun 30, 2025 157,000.00
Mar 31, 2025 43,000.00
Dec 31, 2024 783,000.00
Sep 30, 2024 590,000.00
Jun 30, 2024 1.51 Mn
Mar 31, 2024 188,000.00
Dec 31, 2023 78,000.00
Sep 30, 2023 1.20 Mn
Jun 30, 2023 2.13 Mn
Mar 31, 2023 2.21 Mn
Dec 31, 2022 1.75 Mn
Sep 30, 2022 386,000.00
Jun 30, 2022 544,000.00
Mar 31, 2022 212,000.00
Dec 31, 2021 514,000.00
Sep 30, 2021 223,000.00
API Access

Xenon Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XENE&period=max&api_key=YOUR_API_KEY